Cargando…
Linolenic acid-metronidazole inhibits the growth of Helicobacter pylori through oxidation
BACKGROUND: Resistance to antibiotics is one the main factors constraining the treatment and control of Helicobacter pylori (H. pylori) infections. Therefore, there is an urgent need to develop new antimicrobial agents to replace antibiotics. Our previous study found that linolenic acid-metronidazol...
Autores principales: | Zhou, Wen-Ting, Dai, Yuan-Yuan, Liao, Li-Juan, Yang, Shi-Xian, Chen, Hao, Huang, Liang, Zhao, Juan-Li, Huang, Yan-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494766/ https://www.ncbi.nlm.nih.gov/pubmed/37701137 http://dx.doi.org/10.3748/wjg.v29.i32.4860 |
Ejemplares similares
-
Linolenic Acid-Metronidazole: a Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori
por: Dai, Yuan-Yuan, et al.
Publicado: (2022) -
Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori
por: Li, Xiao-Hua, et al.
Publicado: (2021) -
BanXiaXieXin decoction treating gastritis mice with drug-resistant Helicobacter pylori and its mechanism
por: Li, Xiao-Hua, et al.
Publicado: (2023) -
PBX1 attributes as a determinant of connexin 32 downregulation in Helicobacter pylori-related gastric carcinogenesis
por: Liu, Xiao-Ming, et al.
Publicado: (2017) -
Helicobacter pylori inhibits the cleavage of TRAF1 via a CagA-dependent mechanism
por: Wan, Xiu-Kun, et al.
Publicado: (2016)